Condition: Type 2 Diabetes Treated With Insulin · Sponsor: Aalborg University Hospital
The trial is an open-label, randomized controlled trial. Patients with T2D on insulin therapy will be randomized to an intelligent telemonitoring group (intervention), a telemonitoring group (control), and a usual care group (control). Both the intelligent telemonitoring group and the telemonitoring group will use various devices at home. Hospital staff will monitor their data for three months. In the intelligent telemonitoring group, hospital staff and participants will be supported by decision-support algorithms in the management of insulin treatment.
This description comes directly from the study's public registry record.
Jannie Nørlev, PhD · 004523676513 · jadano@hst.aau.dk
Stine Hangaard, PhD · svh@hst.aau.dk
Always discuss trial participation with your own doctor first.
| Department of Endocrinology | Aalborg, North Jutland, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06185296